Curaleaf Grows Florida Retail Presence with Riverview Dispensary Opening
MWN-AI** Summary
Curaleaf Holdings, Inc., a prominent player in the cannabis industry, has announced the opening of its new dispensary in Riverview, Florida, bringing its total dispensary count in the state to 77 and 178 nationwide. This outlet is strategically located in the Tampa Bay area, an increasingly lucrative suburban market that has shifted from its rural origins to become a thriving community for young professionals.
Curaleaf Riverview offers a variety of cannabis products tailored specifically for medical patients, including exclusive local brands like Reef flower and Dark Heart ultra-premium flower. The dispensary aims to enhance the shopping experience with a curated selection designed to meet the diverse needs of its customers. According to CEO Boris Jordan, this opening is a part of a broader initiative to accelerate Curaleaf's presence in Florida's expanding medical cannabis market, reflecting the company's strategic commitment to delivering patient-centered services and product accessibility.
The grand opening of Curaleaf Riverview is set for September 18 and 19, 2026, and will feature promotional activities, brand activations, and giveaways, creating buzz in the community. The dispensary will operate Monday through Saturday from 9:00 AM to 8:30 PM ET, and on Sundays from 10:00 AM to 7:00 PM ET, facilitating convenient access for customers.
Curaleaf continues to be recognized for its comprehensive approach to cannabis, blending quality product offerings with a commitment to patient care. The company operates multiple brands like Select, Anthem, and Grassroots, and maintains a robust distribution network across several regions, including Europe and Canada. As it continues to expand, Curaleaf remains focused on its mission to enhance lives through the power of cannabis.
MWN-AI** Analysis
Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) continues to solidify its foothold in the burgeoning Florida medical cannabis market with the recent opening of its 77th dispensary in Riverview. This strategic expansion, part of a broader push to enhance retail presence across Florida, is indicative of Curaleaf's commitment to capturing market share in one of the nation's fastest-growing cannabis landscapes.
Riverview's positioning in the Tampa Bay area, a community that has transitioned into a vibrant hub for young professionals, offers an opportunity for Curaleaf to tap into an expanding customer base that increasingly seeks convenient access to quality cannabis products. The dispensary's diverse product offerings—including Reef flower and Select Briq vape—are tailored to meet the needs of local medical patients, enhancing customer experience and brand loyalty.
Investors should monitor Curaleaf's performance closely as it continues to capitalize on Florida's regulatory framework, which has proven favorable for medical cannabis. The company’s expansion efforts are underpinned by a robust operational strategy that emphasizes quality, accessibility, and patient-centered services—key drivers of revenue growth.
However, potential investors should be cognizant of the inherent risks in the cannabis sector, including regulatory changes and market competition. Analyzing Curaleaf's financial health, growth metrics, and operational efficiency will be crucial for making informed investment decisions. With the cannabis market evolving rapidly, Curaleaf’s proactive approach to expansion may yield long-term gains, making it a noteworthy contender in an increasingly competitive market.
In summary, Curaleaf’s Riverview dispensary opening is a significant milestone that aligns with its long-term growth strategy. Investors seeking exposure to the cannabis sector should consider Curaleaf for its strategic positioning and commitment to quality, but remain mindful of market volatility and regulatory challenges.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Canada NewsWire
Latest opening brings the Company's Florida dispensary count to 77 and 178 nationwide
STAMFORD, Conn., Sept. 4, 2026 /CNW/ -- Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer cannabis products, today announced the opening of Curaleaf Riverview, located at 10422 US Hwy 301 S, Riverview, FL 33578. With this opening, the Company's retail footprint grows to 77 dispensaries in Florida and 178 nationwide.
Located in the Tampa Bay area, Curaleaf Riverview is situated in a rapidly growing suburban community that has evolved from its rural roots along the Alafia River into a thriving hub for young professionals and businesses. With convenient access to Tampa, Brandon, Apollo Beach and the broader South Shore area, Riverview continues to see significant residential, retail and economic growth, making it an increasingly important community in the region. The dispensary features a broad range of products and brands for medical patients, including Curaleaf's Florida-exclusive Reef flower, Dark Heart ultra-premium flower, FIND flower, Anthem pre-rolls and the Select Briq 2 all-in-one vape.
"Our newest dispensary in the Tampa area is the latest of several openings in the state since the beginning of the year," said Boris Jordan, Chairman and CEO of Curaleaf. "This acceleration in the Florida market reflects our long-term strategy to strengthen our presence in this fast-growing medical cannabis market. As we continue to expand, we are focused on providing access to comprehensive, curated products offerings and patient-centered services that enhance the shopping experience."
A grand opening celebration will take place all day at Curaleaf Riverview on September 18 and 19, 2026, featuring brand activations, in-store promotions, and giveaways while supplies last. The dispensary will operate from Monday through Saturday from 9:00 A.M. to 8:30 P.M. ET, and 10:00 A.M. to 7:00 P.M. ET on Sundays.
For more information on Curaleaf's Florida dispensaries, products, and patient resources, please visit https://curaleaf.com/dispensary/florida.
About Curaleaf Holdings
Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf") is a leading international provider of consumer products in cannabis with a mission to enhance lives by cultivating, sharing and celebrating the power of the plant. As a high-growth cannabis company known for quality, expertise and reliability, the Company and its brands, including Curaleaf, Select, Grassroots, Find, Dark Heart, and Anthem provide industry-leading service, product selection and accessibility across the medical and adult use markets. Curaleaf International is powered by a strong presence in all stages of the supply chain. Its unique distribution network throughout Europe, Canada and Australasia brings together pioneering science and research with cutting-edge cultivation, extraction and production. Curaleaf is listed on the Toronto Stock Exchange under the symbol CURA and trades on the OTCQX market under the symbol CURLF. For more information, please visit https://ir.curaleaf.com.
Forward Looking Statements
This media advisory contains forward-looking statements and forward-looking information within the meaning of applicable securities laws. These statements relate to future events or future performance. All statements other than statements of historical fact may be forward–looking statements or information. Generally, forward-looking statements and information may be identified by the use of forward-looking terminology such as "plans", "expects" or "proposed", "is expected", "intends", "anticipates", or "believes", or variations of such words and phrases, or by the use of words or phrases which state that certain actions, events or results may, could, would, or might occur or be achieved. More particularly and without limitation, this news release contains forward-looking statements and information concerning the opening of a dispensary in Riverview, Florida. Such forward-looking statements and information reflect management's current beliefs and are based on assumptions made by and information currently available to the company with respect to the matter described in this new release. Forward-looking statements involve risks and uncertainties, which are based on current expectations as of the date of this release and subject to known and unknown risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. Additional information about these assumptions and uncertainties is discussed in the Company's Form 8-K dated August 5, 2026 together with the annual report on Form 10-K for the year ended December 31, 2025 and the quarterly report on Form 10-Q for the quarter ended March 31, 2026, attached as exhibits thereto, as well as the Form 10-Q for the quarter ended June 30, 2026, each of which documents have been filed on the Company's EDGAR profile at www.sec.gov/edgar and SEDAR+ profile at www.sedarplus.ca, and as described from time to time in documents filed by the Company with the U.S. Securities and Exchange Commission and the Canadian securities regulatory authorities. Forward-looking statements contained herein are made only as to the date of this press release and we undertake no obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, except as required by law. We caution investors not to place considerable reliance on the forward-looking statements contained in this press release. The Toronto Stock Exchange has not reviewed, approved or disapproved the content of this news release.
Investor Contact:
Curaleaf Holdings, Inc.
Camilo Lyon, Chief Investment Officer
IR@curaleaf.com
Media Contact:
MATTIO Communications
MattioCuraleaf@Mattio.com
SOURCE Curaleaf Holdings, Inc.
View original content to download multimedia: http://www.newswire.ca/en/releases/archive/September2026/04/c3254.html
FAQ**
How does the opening of Curaleaf Riverview contribute to Curaleaf's long-term strategy in Florida's medical cannabis market, particularly in relation to its stock performance, CURA:CC?
What specific product offerings will Curaleaf Riverview provide, and how might these impact customer engagement in the rapidly growing community, relevant to CURA:CC?
What metrics will Curaleaf use to evaluate the success of the new Riverview dispensary compared to its other 76 locations in Florida, especially considering investor expectations regarding CURA:CC?
How does Curaleaf plan to navigate potential risks and uncertainties associated with expanding its retail presence in Florida, as it pertains to future growth and CURA:CC?
**MWN-AI FAQ is based on asking OpenAI questions about Curaleaf Holdings Inc (OTC: CURLF).
NASDAQ: CURLF
CURLF Trading
-2.44% G/L:
$9.61 Last:
11,733 Volume:
$9.77 Open:
CURLF Latest News
